Trial intelligence / Profile preview

Conversion to Cyclosporine A in NODAT

NCT01268995Phase 2Terminated

Sponsor
Medical University of Vienna
Start
Sep 2009
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cyclosporine in post-transplant diabetes mellitus (PTDM), sponsored by Medical University of Vienna. Started Sep 2009; status: terminated.

02

Drugs

cyclosporine
03

Conditions

post-transplant diabetes mellitus (PTDM)

Beyond the preview

Go deeper on NCT01268995.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01268995.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call